Xcout IntelSign inSubscribe

Xtant Medical Holdings, Inc.

XTNTMedical DevicesBelgrade, United States

Xtant Medical Holdings, Inc., a company based in Belgrade, Montana, specializes in the development, production, and distribution of advanced regenerative medicine products and medical devices. The firm primarily serves orthopedic and neurological surgeons both within the United States and globally. Its comprehensive product portfolio is categorized into several key areas: 1. Biomaterial Offerings: This category includes products like OsteoSponge, which provides a natural structural support for cellular growth and introduces vital bone-forming proteins to aid the healing process. OsteoSponge SC is specifically designed to repair bone defects in the subchondral area of joints. Other items are OsteoSelect DBM Putty, fostering osteoinductive bone regeneration, and OsteoSelect PLUS DBM Putty, which functions as a bone void filler and graft substitute for procedures involving the pelvis, extremities, and posterolateral spine. Additionally, the line features OsteoFactor, containing diverse proteins and peptides that facilitate bone formation and remodeling, along with OsteoWrap and OsteoVive Plus, a cellular bone matrix enriched with growth factors. 2. Allograft Technologies: Under the 3Demin brand, Xtant Medical provides a range of allografts (human bone grafts) engineered to maximize both osteoconductivity and osteoinductive capabilities. This includes specialized sports allografts used for repairing anterior and posterior cruciate ligaments, ACL reconstruction, and meniscal repairs. They also offer milled spinal allografts, where cortical bone is precisely shaped to specific dimensions, as well as traditional allografts applicable across numerous medical disciplines such such as orthopedics, neurology, podiatry, oral/maxillofacial surgery, genitourinary, and plastic/reconstructive surgery. 3. Spinal Fixation and Fusion Systems: The company furnishes a variety of sophisticated spinal devices. These include the Certex spinal fixation system, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, the Xpress minimally invasive pedicle screw system, and Fortex Pedicle screw systems. Further systems encompass Calix, for use in cervical and thoracolumbar regions, the Axle-X interspinous fusion system, Irix-C for cervical integrated fusion, and the Irix-A Lumbar integrated fusion system. The company underwent a name change in July 2015, transitioning from its former identity as Bacterin International Holdings, Inc. to Xtant Medical Holdings, Inc.

Subscribe to see Xtant Medical Holdings, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Xtant Medical Holdings, Inc. at a glance

Xtant Medical Holdings, Inc. is a medical devices company headquartered in Belgrade, United States. It is publicly listed (XTNT) with a market capitalisation of $61.7M. Xcout tracks 19 named people at Xtant Medical Holdings, Inc., including Sean E. Browne (President, Chief Executive Officer & Director).

Industry
Medical Devices
Headquarters
Belgrade, United States
Market cap
$61.7M
Employees
217
Ticker
XTNT

Xtant Medical Holdings, Inc. leadership

  • Sean E. BrownePresident, Chief Executive Officer & Director
  • Sean BrowneChief Executive Officer
  • Scott C. NeilsChief Financial Officer
  • Mark SchallenbergerChief Operations Officer
  • Catherine LundyVice President of Human Resources
  • John BakewellDirector, Chair of the Audit Committee, Corporate Governance and Nominating Committee

13 more named people on record for Xtant Medical Holdings, Inc., with roles, board committees and tenure — see the full roster →

Xtant Medical Holdings, Inc. competitors

A few of Xtant Medical Holdings, Inc.'s closest competitors — see the full list of competitors and alternatives →

Baxter International Inc.BAX · Medical DevicesDeerfield, United States
63% matchPublic

Baxter International Inc. is a global healthcare company that develops and supplies a broad spectrum of medical products and services through its various subsidiaries. The company's offerings encompass vital areas such as kidney care, including peritoneal and hemodialysis solutions, along with related therapies and services. It provides essential intravenous (IV) solutions, infusion pumps, administration sets, and drug reconstitution devices. Additionally, Baxter supports hospital pharmacies with premixed and oncology drug formulations, inhaled anesthetics, critical care products, and compounding services. For surgical procedures, Baxter manufactures biological products and medical devices designed to facilitate hemostasis, tissue sealing, and adhesion prevention. It also specializes in intensive care unit (ICU) treatments like continuous renal replacement and other organ support therapies. The company's portfolio extends to integrated connected care solutions, featuring advanced devices, software, communication tools, and integration technologies. Furthermore, Baxter delivers comprehensive patient monitoring and diagnostic tools for detecting, treating, and managing a wide range of illnesses, including respiratory, cardiac, vision, and physical assessment needs, as well as providing specialized surgical suite equipment like video systems, operating tables, and precision positioning devices. Beyond its own products, Baxter offers contract manufacturing and development services to pharmaceutical and biopharmaceutical partners. These diverse products and services are utilized across numerous healthcare settings, from hospitals, kidney dialysis centers, nursing homes, and rehabilitation facilities to doctors' offices and directly by patients at home under medical supervision. Baxter markets its offerings in approximately 100 countries, leveraging a direct sales force, independent distributors, drug wholesalers, and specialized pharmacy or alternative site channels. Established in 1931 and headquartered in Deerfield, Illinois, the company also has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules.

Market cap$12.6B
Employees37,500
Baxter International Inc. competitors & alternatives →

Get Xtant Medical Holdings, Inc.'s news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Xtant Medical Holdings, Inc. — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Xtant Medical Holdings, Inc. in Xcout Intel

  • 19 named people with titles, LinkedIn and board committees
  • 8 corporate events with sources — deals, leadership changes, layoffs
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →